Growth Hormone Deficiency
Endocrinology·MeSH: Dwarfism, Pituitary
Prevalence
30.0 / 100K
10 drugs in development·5 companies·6 clinical trials
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| skytrofa | Ascendis Pharma A/S (ASND) |
Phase 3(6)
Compare drugs
Frequently asked questions
How many drugs are in development for Growth Hormone Deficiency?
BioSniper tracks 10 drugs in development for Growth Hormone Deficiency across 5 companies.
How many clinical trials target Growth Hormone Deficiency?
There are 6 clinical trials targeting Growth Hormone Deficiency tracked by BioSniper.
What is the prevalence of Growth Hormone Deficiency?
The estimated prevalence of Growth Hormone Deficiency is approximately 30.0 per 100,000 population.
Deep-dive into Growth Hormone Deficiency
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis